Sialic acid-containing lipopolysaccharides of salmonella O48 strains-potential role in camouflage and susceptibility to the bactericidal effect of normal human serum

Microbial Ecology

Volumn 59, Issue 3, 2010, Pages 601-613

  Bugla Płoskońska, Gabriela ^a   Rybka, Jacek ^b   Futoma Kołoch, Bozena ^a   Cisowska, Agnieszka ^c   Gamian, Andrzej ^b,c   Doroszkiewicz, Włodzimierz ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA (MICROORGANISMS); NEGIBACTERIA; SALMONELLA;

3 DEOXY MANNO OCT 2 ULOPYRANOSONIC ACID; 3-DEOXY-MANNO-OCT-2-ULOPYRANOSONIC ACID; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; N ACETYLNEURAMINIC ACID; SUGAR ACID;

ARTICLE; BLOOD; CHEMISTRY; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; HUMAN; MASS FRAGMENTOGRAPHY; PATHOGENICITY; SALMONELLA; SERUM BACTERICIDAL ACTIVITY;

BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT PATHWAY, ALTERNATIVE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; N-ACETYLNEURAMINIC ACID; SALMONELLA; SUGAR ACIDS;

EID: 77952532577     PISSN: 00953628     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00248-009-9600-2     Document Type: Article

References (38)

1. Bugla-Płoskońska G, Kiersnowski A, Futoma-Kołoch B, Doroszkiewicz W (2009) Killing of gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement protein in the death of Salmonella strains O48. Microb Ecol 58: 276-289.
2. Bugla-Płoskońska G, Doroszkiewicz W (2006) Bactericidal activity of normal bovine serum (NBS) directed against some Enterobacteriaceae with sialic acid-containing lipopolysaccharides (LPS) as a component of cell wall. Pol J Microb 55: 169-174.
3. Bugla-Płoskońska G, Cisowska A, Karpińska K, Jankowski S, Doroszkiewicz W (2006) The mechanisms of the activation of normal human serum complement by Escherichia coli strains with K1 surface antigen. Folia Microbiol 51: 627-632.
4. Bugla-Płoskońska G, Korzeniowska-Kowal A, Gamian A, Doroszkiewicz W (2004) Bactericidal activity of serum against Salmonella O48 serovars. Int J Antimicrobiol Ag 24: 203.
5. Ciurana B, Tomás JM (1987) Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun 11: 2741-2746.
6. Doroszkiewicz W (1997) Mechanism of antigenic variation in Shigella flexneri bacilli. IV. Role lipopolysaccharides and their components in the sensitivity of Shigella flexneri 1b and its Lac + recombinant to killing action of serum. Arch Immunol Ther Exp 45: 235-242.
7. Edinger D, Bello E, Mates A (1977) The heterocytotoxicity of human serum. I. Activation of the alternative complement pathway by heterologous target cells. Cell Immunol 29: 174-186.
8. Erridge C, Bennett-Guerrero E, Paxton IR (2002) Structure and function of lipopolysaccharides. Microb Infect 4: 837-851.
9. Fine DP, Marney SR, Colley DG, Sergent JS, Des Prez RM (1972) C3 shunt activation in human serum chelated with EGTA. J Immunol 109: 807-809.
10. Gamian A, Jones C, Lipiński T, Korzeniowska-Kowal A, Ravenscroft N (2000) Structure of the sialic acid-containing O-specific polysaccharide from Salmonella enterica serovar Toucra O48 lipopolysaccharide. Eur J Biochem 267: 3160-3167.
11. Gamian A, Kenne L (1993) Analysis of 7-substituted sialic acid in some enterobacterial lipopolysaccharides. J Bacteriol 175: 1508-1513.
12. Gamian A, Romanowska A, Romanowska E (1992) Immunochemical studies on sialic acid-containing lipopolysaccharides from enterobacterial species. FEMS Microbiol Immunol 89: 323-328.
13. Giammanco GM, Pignato S, Mammina C, Grimont F, Grimont PA, Nastasi A, Giammanco G (2002) Persistent endemicity of Salmonella bongori 48: z35 in Southern Italy: molecular characterization of human, animal and environmental isolates. J Clin Microbiol 9: 3502-3505.
14. Grimond PD, Weill FX (2007) Antigenic formulae of the Salmonella serovars, 9th ed. WHO Collaborating Centre for Reference and Research on Salmonella.
15. Holland MCH, Lambris JD (2005) Complement: Encyclopedia of life sciences. Wiley, UK.
16. Joiner KA, Hammer CH, Brown EJ, Cole RJ, Frank MM (1982) Studies on the mechanism of bacterial resistance to complement mediated-killing. I. Terminal complement components are deposited and released from Salmonella Minnesota S218 without causing bacterial death. J Exp Med 155: 797-808.
17. Koistinen V (1992) Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement. Biochem J 283: 317-319.
18. Meri S, Pangburn MK (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 87: 3982-3986.
19. Mielnik G, Gamian A, Doroszkiewicz W (2001) Bactericidal activity of normal cord serum (NCS) against Gram-negative rods with sialic acid-containing lipopolysaccharides (LPS). FEMS Immunol Med Microbiol 31: 169-173.
20. Moran AP, Prendergast MM, Appelmelk BJ (1996) Molecular mimicry of host structures by bacterial lipopolysaccharides and its contribution to disease. FEMS Immunol Med Microbiol 16: 105-115.
21. Odumeru JA, Wiseman GM, Ronald AR (1985) Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducrei to human serum. Infect Immun 50: 495-499.
22. Ourth DD, Bachinski LM (1987) Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus). Dev Comp Immunol 11: 551-564.
23. Prescott LM, Harley JP, Klein DA (2002) Microbiology, 5th edn. McGraw-Hill, Boston.
24. Ram S, Sharma AK, Simpson SD, Gulati S, Mcquillen DP, Pangburn MK, Rice PA (1998) A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 187: 743-752.
25. Rautemaa R, Meri S (1999) Complement-resistance mechanisms of bacteria. Microb Infect 1: 785-794.
26. Ringenberg MA, Steenbergen SM, Vimr ER (2003) The first committed step in the biosynthesis of sialic acid by Escherichia coli K1 does not involve a phosphorylated N-acetylmannosamine intermediate. Mol Microbiol 50: 961-975.
27. Rybka J, Gamian A (2006) Determination of endotoxin by the measurement of the acetylated methyl glycoside derivative of Kdo with gas-liquid chromatography-mass spectrometry. J Microbiol Meth 64: 171-184.
28. Schmidt BZ, Colten HR (2000) Complement: a critical test of its biological importance. Immunol Rev 178: 166-176.
29. Schröter M, Roggentin P, Hofman J, Speicher A, Laufs R, Mack D (2004) Pet snakes as a reservoir for Salmonella enterica subsp. diarizonae (serogroup IIIb): a prospective study. Appl Environ Microb 70: 613-615.
30. Selander B, Martensson U, Wientraub A, Holmström E, Matsushita M, Thiel S, Jensenius JC, Truedsson L, Sjöholm AG (2006) Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 116: 1425-1434.
31. Ślopek S (1970) Immunologia praktyczna. Państwowy Zakład Wydawnictw Lekarskich, Warszawa in Polish.
32. Taylor PW (1983) Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microb Rev 1: 46-83.
33. Taylor PW, Kroll HP, Tomlinson S (1982) Effect of subinhibitory concentrations of mecillinam on expression of Escherichia coli surface components associated with serum resistance. Drugs Exp Clin Res 8: 625-631.
34. Taylor PW, Gaunt H, Unger FM (1981) Effect of subinhibitory concentration of meticillinam on the serum susceptibility of Escherichia coli strains. Antimicrob Ag Chemother 19: 786-788.
35. Uzzau S, Brown DJ, Wallis T, Rubino S, Leori G, Bernerd S, Casadesus J, Platt DJ, Olsen JE (2000) Host adapted serotypes of Salmonella enterica. Epidemiol Infect 125: 229-255.
36. Waterman SH, Juarez G, Carr SJ, Kilman L (1990) Salmonella ariozona infections in Latinos associated with rattlesnake folk medicine. Am J Pub Health 80: 286-289.
37. World Health Organization. Drug-resistant Salmonella. Fact sheet N°139. Revised April 2005.
38. World Health Organization. Food and Agriculture Organization of the United Nations. FAO/WHO Expert Meeting on Salmonella and Campylobacter in chicken meat. FAO Headquarters, Rome, Italy, 4-9 May 2009.